Adagene Inc., an innovative clinical-stage biotechnology firm, has made it to the front page with the announcement of a multi-target platform evaluation with the American biotechnology company, Celgene Corporation. As per the terms of the agreement, Adagene is expected to deploy its Dynamic Precision Library …
A clinical-stage specialty pharmaceutical company Taiwan Liposome Company Ltd. and 3SBio Inc, China’s leading biopharmaceutical company have reportedly entered into an exclusive partnership intended to commercialize two liposomal products in China, using TLC’s proprietary NanoX technology platform. As per the alliance, TLC and 3SBio will …
Innovative molecular diagnostics firm Biocartis Group NV has recently announced the CE-IVD marking of its completely automated Idylla™ MSI Test, which enables accurate and fast information regarding a patients MSI status, directly from a single FFPE (formalin fixed, paraffin embedded) sample of colorectal cancer (CRC) …
With the Fast Track designation, Iovance is likely to increase the frequency of its communication with the U.S. FDA. Reputed biotechnology company Iovance Biotherapeutics, Inc., has reportedly been granted the Fast Track designation for its adoptive cell therapy LN-145, developed using its proprietary TIL manufacturing …
In a recent turn of events, Bausch + Lomb, an eye health behemoth and a fully owned business unit of Bausch Health Companies Incorporation, has reportedly declared that the United States Food and Drug Administration has given approval to LOTEMAX® SM 0.38 percent, a novel …
In a recent turn of events, biopharmaceutical giant AstraZeneca’s Brilinta has reportedly cleared its phase 3 patient trial called Themis. According to sources familiar with the development, Brillinta when consumed in conjunction with aspirin reduces the combined risk of stroke, heart attack, and cardiovascular death …
Roche Holding AG, the Swiss healthcare giant, has reportedly announced its acquisition of the U.S.-based gene therapy specialist and pharmaceutical company, Spark Therapeutics. With the latest buyout, Roche intends to build its hemophilia portfolio and maintain pace in gene therapy. As per authentic sources, the …
The latest move underlines MediPharm’s first international export deal. AusCann Group Holdings Ltd. (AC8), an Australian cannabis medicine company, has reportedly entered into a supply agreement with the leading cannabis extractor in Canada, MediPharm Labs Corp., for the purchase of cannabis resin. AusCann, for the …
The study specifies the possibility of preventing or delaying kidney failure and the need for dialysis or a kidney transplant in patients with rare chronic kidney disease. U.S. clinical-stage biopharmaceutical firm, Reata Pharmaceuticals, Inc. has recently announced its final, positive result from the focal segmental …
